NIH on tobacco
This article was originally published in The Tan Sheet
Effective provider-reimbursement policies for tobacco control need to be developed to make progress towards the public health benefits of quitting tobacco use, according to a 14-member NIH State-of-the-Science conference panel on tobacco use. The panel, which met June 12-14, pointed out that tobacco use remains the U.S.'s leading preventable cause of premature death with more than 440,000 American deaths per year as a result of a tobacco-related disease. Panelists also found that interventions and treatments aimed at helping smokers quit such as nicotine replacement therapy, telephone quitlines and counseling, all were effective individually, but were even more successful when combined...
You may also be interested in...
Chief medical officer Samit Hirawat outlines R&D successes – though there have been some setbacks since it bought Celgene for $74bn last year – and the company’s commitment to clinical trial diversity.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.